 HIV
"HIV" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
| Descriptor ID |
D006678
|
| MeSH Number(s) |
B04.820.650.589.650.350
|
| Concept/Terms |
HIV- HIV
- Human Immunodeficiency Virus
- Immunodeficiency Virus, Human
- Immunodeficiency Viruses, Human
- Virus, Human Immunodeficiency
- Viruses, Human Immunodeficiency
- Human Immunodeficiency Viruses
- Human T Cell Lymphotropic Virus Type III
- Human T-Cell Lymphotropic Virus Type III
- Human T-Cell Leukemia Virus Type III
- Human T Cell Leukemia Virus Type III
- LAV-HTLV-III
- Lymphadenopathy-Associated Virus
- Lymphadenopathy Associated Virus
- Lymphadenopathy-Associated Viruses
- Virus, Lymphadenopathy-Associated
- Viruses, Lymphadenopathy-Associated
- Human T Lymphotropic Virus Type III
- Human T-Lymphotropic Virus Type III
- AIDS Virus
- AIDS Viruses
- Virus, AIDS
- Viruses, AIDS
- Acquired Immune Deficiency Syndrome Virus
- Acquired Immunodeficiency Syndrome Virus
- HTLV-III
|
Below are MeSH descriptors whose meaning is more general than "HIV".
Below are MeSH descriptors whose meaning is more specific than "HIV".
This graph shows the total number of publications written about "HIV" by people in this website by year, and whether "HIV" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 3 | 3 | | 1996 | 2 | 1 | 3 | | 1997 | 0 | 1 | 1 | | 1998 | 0 | 1 | 1 | | 2000 | 2 | 0 | 2 | | 2003 | 2 | 1 | 3 | | 2004 | 2 | 1 | 3 | | 2005 | 2 | 1 | 3 | | 2006 | 3 | 0 | 3 | | 2007 | 5 | 3 | 8 | | 2008 | 2 | 1 | 3 | | 2009 | 2 | 1 | 3 | | 2010 | 3 | 3 | 6 | | 2011 | 3 | 5 | 8 | | 2012 | 5 | 3 | 8 | | 2013 | 3 | 3 | 6 | | 2014 | 4 | 4 | 8 | | 2015 | 0 | 1 | 1 | | 2016 | 1 | 2 | 3 | | 2017 | 2 | 7 | 9 | | 2018 | 5 | 8 | 13 | | 2019 | 3 | 5 | 8 | | 2020 | 1 | 8 | 9 | | 2021 | 0 | 10 | 10 | | 2022 | 1 | 12 | 13 | | 2023 | 0 | 9 | 9 |
To return to the timeline, click here.
Below are the most recent publications written about "HIV" by people in Profiles.
-
Moore M, Stansfield S, Donnell DJ, Boily MC, Mitchell KM, Anderson PL, Delany-Moretlwe S, Bekker LG, Mgodi NM, Celum CL, Dimitrov D. Efficacy estimates of oral pre-exposure prophylaxis for HIV prevention in cisgender women with partial adherence. Nat Med. 2023 Nov; 29(11):2748-2752.
-
Lesko CR, Falade-Nwulia OO, Pytell JD, Hutton HE, Fojo AT, Keruly JC, Moore RD, Chander G. Joint effects of substance use disorders and recent substance use on HIV viral non-suppression among people engaged in HIV care in an urban clinic, 2014-2019. Addiction. 2023 11; 118(11):2193-2202.
-
Higgins DM, Moore M, Alderton L, Weinberg L, Hickok AM, Yale A, Wendel KA. Evaluation of a Statewide Online, At-Home Sexually Transmitted Infection and Human Immunodeficiency Virus Screening Program. Clin Infect Dis. 2023 06 16; 76(12):2148-2153.
-
Anderson PL, Marzinke MA, Glidden DV. Updating the Adherence-Response for Oral Emtricitabine/Tenofovir Disoproxil Fumarate for Human Immunodeficiency Virus Pre-Exposure Prophylaxis Among Cisgender Women. Clin Infect Dis. 2023 05 24; 76(10):1850-1853.
-
Phelan MP, Panakkal V, Muir M, Seballos S, Kadkhoda K. Emergency Department Co-testing for Human Immunodeficiency Virus When Testing for Gonorrhea and Chlamydia: A Readily Available, Missed Opportunity for Targeted HIV Testing in Emergency Departments. Am J Clin Pathol. 2023 03 13; 159(3):225-227.
-
Brooks KM, Scarsi KK, Mirochnick M. Antiretrovirals for Human Immunodeficiency Virus Treatment and Prevention in Pregnancy. Obstet Gynecol Clin North Am. 2023 Mar; 50(1):205-218.
-
Beauchamp G, Hosek S, Donnell DJ, Chan KCG, Flaherty BP, Anderson PL, Dye BJ, Mgodi N, Bekker LG, Delany-Moretlwe S, Celum C. Development of a tool to assess HIV prevention readiness of adolescent girls and young women in HPTN 082 study. PLoS One. 2023; 18(2):e0281728.
-
Schnittman SR, Lu MT, Mayrhofer T, Burdo TH, Fitch KV, McCallum S, Fulda ES, Zanni MV, Foldyna B, Malvestutto C, Fichtenbaum CJ, Aberg JA, Bloomfield GS, Overton ET, Currier J, Tebas P, Sha BE, Ribaudo HJ, Flynn JM, Douglas PS, Erlandson KM, Grinspoon SK. Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV). Clin Infect Dis. 2023 02 08; 76(3):e613-e621.
-
Zanni MV, Foldyna B, McCallum S, Burdo TH, Looby SE, Fitch KV, Fulda ES, Autissier P, Bloomfield GS, Malvestutto CD, Fichtenbaum CJ, Overton ET, Aberg JA, Erlandson KM, Campbell TB, Ellsworth GB, Sheth AN, Taiwo B, Currier JS, Hoffmann U, Lu MT, Douglas PS, Ribaudo HJ, Grinspoon SK. Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States. Clin Infect Dis. 2023 01 13; 76(2):323-334.
-
Garcia-Cremades M, Vucicevic K, Hendrix CW, Jayachandran P, Jarlsberg L, Grant R, Celum CL, Martin M, Baeten JM, Marrazzo J, Anderson P, Choopanya K, Vanichseni S, Glidden DV, Savic RM. Characterizing HIV-Preventive, Plasma Tenofovir Concentrations-A Pooled Participant-level Data Analysis From Human Immunodeficiency Virus Preexposure Prophylaxis Clinical Trials. Clin Infect Dis. 2022 11 30; 75(11):1873-1882.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|